Cyclacel Pharmaceuticals(CYCC)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CYCC Cyclacel Pharmaceuticals

未开盘 04-24 16:00:00 EDT

2.30

+0.51

+28.49%

盘后2.57

+0.27+11.74%

19:59 EDT

最高2.35	最低1.85	成交量55.10万
今开1.86	昨收1.79	日振幅27.93%
总市值303.19万	流通市值264.95万	总股本131.83万
成交额120.59万	换手率47.83%	流通股本115.20万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CYCC","market":"US","secType":"STK","nameCN":"Cyclacel Pharmaceuticals","latestPrice":2.2999,"timestamp":1713988800000,"preClose":1.79,"halted":0,"volume":550958,"hourTrading":{"tag":"盘后","latestPrice":2.57,"preClose":2.2999,"latestTime":"19:59 EDT","volume":222848,"amount":560909.4834,"timestamp":1714003196374},"delay":0,"floatShares":1151993,"shares":1318257,"eps":-26.746119,"marketStatus":"未开盘","marketStatusCode":0,"change":0.5099,"latestTime":"04-24 16:00:00 EDT","open":1.86,"high":2.3499,"low":1.85,"amount":1205876.815978,"amplitude":0.279274,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-26.746119,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714032000000},"adr":0,"listingDate":1079413200000,"adjPreClose":1.79,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.85,"preClose":1.79,"latestTime":"09:17 EDT","volume":100,"amount":185,"timestamp":1713964677031},"postHourTrading":{"tag":"盘后","latestPrice":2.57,"preClose":2.2999,"latestTime":"19:59 EDT","volume":222848,"amount":560909.4834,"timestamp":1714003196374},"volumeRatio":12.67835},"requestUrl":"/m/hq/s/CYCC","defaultTab":"news","newsList":[{"id":"2429113662","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 快速上涨5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429113662","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429113662?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:43","pubTimestamp":1713879781,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时43分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.71%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.07%。其相关个股中，Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Biomx Inc.、Tiziana Life Sciences Ltd涨幅较大，Silo Pharma, Inc.、Nkgen Biotech, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为162.93%、23.33%、5.74%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Immunitybio, Inc.、Azitra Inc，振幅分别为18.68%、18.42%、12.41%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042321430187a66232&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042321430187a66232&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429330920","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429330920","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429330920?lang=zh_cn&edition=full","pubTime":"2024-04-22 22:33","pubTimestamp":1713796416,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日22时33分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.06%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。其相关个股中，Moolec Science Sa C/Wts 、Moolec Science Sa、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Moolec Science Sa、Adial Pharmaceuticals, Inc、亚狮康药业较为活跃，换手率分别为163.57%、56.04%、44.00%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Moolec Science Sa、亚狮康药业，振幅分别为198.51%、68.57%、31.66%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422223336861e7db8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422223336861e7db8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428751982","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 临近午盘股价大跌7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428751982","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428751982?lang=zh_cn&edition=full","pubTime":"2024-04-18 23:44","pubTimestamp":1713455073,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日23时44分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价大幅下跌7.14%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Bio-Path Holdings, Inc.、Aileron Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Bio-Path Holdings, Inc.、Benitec Biopharma Inc.、Soligenix, Inc.较为活跃，换手率分别为8583.74%、99.23%、37.57%，振幅较大的相关个股有Bio-Path Holdings, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Aileron Therapeutics, Inc.，振幅分别为86.72%、73.93%、63.53%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418234433792194ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418234433792194ab&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428617345","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 股价大涨8.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428617345","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428617345?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:35","pubTimestamp":1713360905,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时35分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价大幅上涨8.38%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Psyence Biomedical Ltd C/Wts 25/01/2029、Vanda Pharmaceuticals Inc.涨幅较大，Clearmind Medicine Inc.、Novabay Pharmaceuticals, Inc.、Longeveron Inc.较为活跃，换手率分别为25.51%、22.73%、19.62%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Jaguar Health, Inc.、Viracta Therapeutics, Inc.，振幅分别为25.30%、16.55%、15.75%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417213505861e6b4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417213505861e6b4b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427513881","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 大幅下跌5.11%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427513881","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427513881?lang=zh_cn&edition=full","pubTime":"2024-04-16 01:17","pubTimestamp":1713201452,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日01时17分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.11%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、安皮奥制药、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Longeveron Inc.、Soligenix, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1493.02%、1209.80%、839.99%，振幅较大的相关个股有安皮奥制药、Soligenix, Inc.、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为273.33%、114.53%、80.04%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160117327a52e094&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160117327a52e094&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426294434","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 股价大跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426294434","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426294434?lang=zh_cn&edition=full","pubTime":"2024-04-12 03:25","pubTimestamp":1712863517,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日03时25分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.37%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Rallybio Corporation、Geovax Labs Inc C/Wts 29/09/2025、Eliem Therapeutics, Inc涨幅较大，Adial Pharmaceuticals, Inc、Aptevo Therapeutics Inc.、Scisparc Ltd.较为活跃，换手率分别为880.99%、640.52%、526.65%，振幅较大的相关个股有Veru Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Rallybio Corporation，振幅分别为53.23%、52.42%、50.92%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120325187a523218&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120325187a523218&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426419790","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 大幅下挫5.00%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426419790","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426419790?lang=zh_cn&edition=full","pubTime":"2024-04-10 23:22","pubTimestamp":1712762531,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日23时22分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.00%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.16%。其相关个股中，Adial Pharmaceuticals, Inc、Tc Biopharm  Plc C/Wts 10/02/2028 、Jaguar Health, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1803.58%、75.19%、40.22%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Nutriband Inc C/Wts 、Calidi Biotherapeutics, Inc.，振幅分别为76.11%、52.44%、39.86%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410232212791fafb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410232212791fafb8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425882562","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘大幅下跌7.42%报2.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425882562","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425882562?lang=zh_cn&edition=full","pubTime":"2024-04-05 22:58","pubTimestamp":1712329108,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日22时58分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价大幅跳水7.42%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Moolec Science Sa C/Wts 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Candel Therapeutics, Inc.、Protara Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为105.19%、64.15%、36.79%，振幅较大的相关个股有Protara Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Mink Therapeutics, Inc.，振幅分别为40.80%、39.17%、37.31%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405225828861e38fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405225828861e38fe&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422992973","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 股价大涨8.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422992973","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422992973?lang=zh_cn&edition=full","pubTime":"2024-03-27 21:31","pubTimestamp":1711546274,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日21时31分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价大幅拉升8.85%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Hoth Therapeutics, Inc.较为活跃，换手率分别为806.52%、359.48%、48.65%，振幅较大的相关个股有Lixte Biotechnology Holdings, Inc.、Ibio, Inc.、Annexon, Inc.，振幅分别为19.29%、16.52%、15.19%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032721311487bc7b4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032721311487bc7b4b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422753521","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 股价大跌5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422753521","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422753521?lang=zh_cn&edition=full","pubTime":"2024-03-26 02:12","pubTimestamp":1711390338,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日02时12分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.39%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Landos Biopharma, Inc.、Clene Inc C/Wts 30/12/2025 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Altamira Therapeutics Ltd.、Xtl生物制药、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为3292.55%、447.21%、78.82%，振幅较大的相关个股有Altamira Therapeutics Ltd.、Xtl生物制药、Zura Bio Limited，振幅分别为80.35%、78.61%、47.80%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032602121987e7b8ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032602121987e7b8ac&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421824184","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 急速跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421824184","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421824184?lang=zh_cn&edition=full","pubTime":"2024-03-23 03:50","pubTimestamp":1711137029,"startTime":"0","endTime":"0","summary":"北京时间2024年03月23日03时50分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.04%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Virios Therapeutics, Inc.涨幅较大，Outlook Therapeutics, Inc.、Adial Pharmaceuticals, Inc、180 Life Sciences Corp.较为活跃，换手率分别为96.32%、63.14%、45.53%，振幅较大的相关个股有Virios Therapeutics, Inc.、Moolec Science Sa C/Wts 、Matinas Biopharma Holdings, Inc.，振幅分别为86.19%、75.83%、66.00%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240323035030791c5394&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240323035030791c5394&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420722740","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 临近午盘大幅下跌5.11%报2.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420722740","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420722740?lang=zh_cn&edition=full","pubTime":"2024-03-20 23:51","pubTimestamp":1710949903,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日23时51分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.11%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.81%。其相关个股中，Xtl生物制药、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Moolec Science Sa C/Wts 涨幅较大，Xtl生物制药、Jaguar Health, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为131.46%、77.39%、41.53%，振幅较大的相关个股有Xtl生物制药、Jaguar Health, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为157.69%、38.90%、37.78%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320235143861dfcc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320235143861dfcc9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420793342","title":"Cyclacel Pharmaceuticals, Inc.2023财年实现净利润-22.56百万美元，同比减少6.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420793342","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420793342?lang=zh_cn&edition=full","pubTime":"2024-03-20 15:16","pubTimestamp":1710918982,"startTime":"0","endTime":"0","summary":"12月31日，Cyclacel Pharmaceuticals, Inc.公布财报，公告显示公司2023财年净利润为-22.56百万美元，同比减少6.42%；其中营业收入为420000.00美元，每股基本收益为-26.75美元。从资产负债表来看，Cyclacel Pharmaceuticals, Inc.总负债8.20百万美元，其中短期债务--，资产负债比为1.08，流动比率为0.92。机构评级：截至2023年12月31日，当前有3家机构对Cyclacel Pharmaceuticals, Inc.目标价做出预测，其中目标均价为178.67美元，其中最低目标价为11.00美元，最高目标价为315.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403201516288b4b3e20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403201516288b4b3e20&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420941785","title":"Cyclacel Pharmaceuticals Inc 报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2420941785","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2420941785?lang=zh_cn&edition=full","pubTime":"2024-03-20 05:01","pubTimestamp":1710882086,"startTime":"0","endTime":"0","summary":"   * Cyclacel Pharmaceuticals Inc   报告了截至12月底的季度调整后每股亏损6.23美元，高于去年同期的每股收益9.00美元。三位分析师对该季度的平均预期是每股亏损 5.89 美元。华尔街预期为每股亏损 7.07 美元至 4.98 美元。* Cyclacel Pharmaceuticals Inc 公布的季度每股收益为亏损 6.23 美元。* 该公司的季度亏损额为 532 万美元。* Cyclacel Pharmaceuticals Inc 本季度股价下跌了 6.0%。华尔街对 Cyclacel Pharmaceuticals Inc 的 12 个月目标价中位数为 93.00 美元。本摘要由 LSEG 3 月 19 日 09:00 p.m. UTC 数据机器生成。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2420275984","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘快速跳水5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420275984","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420275984?lang=zh_cn&edition=full","pubTime":"2024-03-19 22:46","pubTimestamp":1710859604,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日22时46分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.57%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Fusion Pharmaceuticals Inc.、Moolec Science Sa C/Wts 、知临集团涨幅较大，Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为809.35%、395.26%、135.78%，振幅较大的相关个股有Enveric Biosciences, Inc.、知临集团、Tracon Pharmaceuticals, Inc.，振幅分别为54.55%、49.87%、47.94%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031922464587e7a183&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031922464587e7a183&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420829052","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 临近收盘股价大涨6.58%报2.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420829052","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420829052?lang=zh_cn&edition=full","pubTime":"2024-03-19 03:48","pubTimestamp":1710791291,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日03时48分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价急速拉升6.58%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Artelo Biosciences Inc C/Wts 20/06/2024 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Zyversa Therapeutics, Inc.、Immuneering Corporation、Jaguar Health, Inc.较为活跃，换手率分别为149.67%、45.72%、38.65%，振幅较大的相关个股有Artelo Biosciences Inc C/Wts 20/06/2024 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Immuneering Corporation，振幅分别为443.52%、71.48%、67.02%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403190348117a4d744d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403190348117a4d744d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419873521","title":"Cyclacel Pharmaceuticals Inc   预计每股亏损5.89美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2419873521","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2419873521?lang=zh_cn&edition=full","pubTime":"2024-03-16 04:13","pubTimestamp":1710533590,"startTime":"0","endTime":"0","summary":"   * Cyclacel Pharmaceuticals Inc    将于3月19日公布截至2023年12月31日的财报，预计季度营收将保持不变。*    * LSEG 的分析师平均预计 Cyclacel Pharmaceuticals Inc 每股亏损 5.89 美元。* 华尔街对 Cyclacel Pharmaceuticals Inc 的 12 个月目标价中位数为 93.00 美元，高于其上次收盘价 2.50 美元。3月15日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2419838501","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.04%报2.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419838501","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419838501?lang=zh_cn&edition=full","pubTime":"2024-03-16 01:44","pubTimestamp":1710524643,"startTime":"0","endTime":"0","summary":"北京时间2024年03月16日01时44分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.04%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，杰龙、Better Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Better Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.、知临集团较为活跃，换手率分别为334.23%、79.58%、33.99%，振幅较大的相关个股有Better Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Outlook Therapeutics, Inc.，振幅分别为114.29%、63.00%、49.39%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403160144037a4d1a7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403160144037a4d1a7e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419707635","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419707635","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419707635?lang=zh_cn&edition=full","pubTime":"2024-03-13 23:05","pubTimestamp":1710342315,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日23时05分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.59%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Nucana Plc、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Kintara Therapeutics, Inc.、Nucana Plc、Tc Biopharm  Plc较为活跃，换手率分别为228.79%、82.75%、41.56%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Tc Biopharm  Plc C/Wts 10/02/2028 、Nucana Plc，振幅分别为82.54%、66.67%、52.21%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403132305157a4c5839&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403132305157a4c5839&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418366618","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 股价大跌5.22%报2.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418366618","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418366618?lang=zh_cn&edition=full","pubTime":"2024-03-11 22:06","pubTimestamp":1710165962,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日22时06分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.22%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Tc Biopharm  Plc、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Tc Biopharm  Plc、180 Life Sciences Corp.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为2473.17%、167.15%、76.82%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Tc Biopharm  Plc、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为137.50%、134.91%、39.82%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031122060287e77c97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031122060287e77c97&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cyclacel.com","stockEarnings":[{"period":"1week","weight":0.1734},{"period":"1month","weight":0.0747},{"period":"3month","weight":0.1057},{"period":"6month","weight":-0.7289},{"period":"1year","weight":-0.7487},{"period":"ytd","weight":-0.1386}],"compareEarnings":[{"period":"1week","weight":0.0097},{"period":"1month","weight":-0.0276},{"period":"3month","weight":0.0356},{"period":"6month","weight":0.2307},{"period":"1year","weight":0.2446},{"period":"ytd","weight":0.0633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cyclacel Pharmaceuticals, Inc.是一家于1996年成立且处于发展阶段的生物制药公司，致力于用于治疗人类癌症和其它重大疾病的新药和与机体有关的药品的开发和商业化。Cyclacel是细胞周期领域的开拓者，它敢于利用仅适合口服的新药来治疗患者。它的目标是在其一系列商业产品和新药筛选机制发展的基础上成为一家着重于血液学、肿瘤学研究的多元化生物医学公司。作为一家处于发展阶段的企业，该公司所有的努力都贡献于其研究和发展上，指导临床试验，开发和收购新的知识产权，提高资金储备和收益率及训练员工。它的目标是开发和商业化面向细胞周期控制各个阶段和用于治疗癌症及其他重大疾病的小分子药物，尤其是那些医疗缺口很大的领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":-0.006177},{"month":2,"riseRate":0.444444,"avgChangeRate":0.08133},{"month":3,"riseRate":0.388889,"avgChangeRate":-0.059058},{"month":4,"riseRate":0.368421,"avgChangeRate":-0.019891},{"month":5,"riseRate":0.388889,"avgChangeRate":-0.025512},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.086137},{"month":7,"riseRate":0.5,"avgChangeRate":-0.041555},{"month":8,"riseRate":0.277778,"avgChangeRate":-0.079},{"month":9,"riseRate":0.5,"avgChangeRate":-0.005826},{"month":10,"riseRate":0.333333,"avgChangeRate":0.010843},{"month":11,"riseRate":0.388889,"avgChangeRate":-0.012713},{"month":12,"riseRate":0.5,"avgChangeRate":-0.018954}],"exchange":"NASDAQ","name":"Cyclacel Pharmaceuticals","nameEN":"Cyclacel Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cyclacel Pharmaceuticals(CYCC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cyclacel Pharmaceuticals(CYCC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cyclacel Pharmaceuticals,CYCC,Cyclacel Pharmaceuticals股票,Cyclacel Pharmaceuticals股票老虎,Cyclacel Pharmaceuticals股票老虎国际,Cyclacel Pharmaceuticals行情,Cyclacel Pharmaceuticals股票行情,Cyclacel Pharmaceuticals股价,Cyclacel Pharmaceuticals股市,Cyclacel Pharmaceuticals股票价格,Cyclacel Pharmaceuticals股票交易,Cyclacel Pharmaceuticals股票购买,Cyclacel Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cyclacel Pharmaceuticals(CYCC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cyclacel Pharmaceuticals(CYCC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况